EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 383 filers reported holding EXELIXIS INC in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $830,496 | +8.4% | 38,009 | -5.2% | 0.00% | +50.0% |
| Q2 2023 | $766,178 | -5.4% | 40,093 | -4.0% | 0.00% | 0.0% |
| Q1 2023 | $810,329 | -1.8% | 41,748 | -18.8% | 0.00% | -33.3% |
| Q4 2022 | $825,098 | +5.6% | 51,440 | +3.3% | 0.00% | 0.0% |
| Q3 2022 | $781,000 | -21.6% | 49,784 | +4.0% | 0.00% | 0.0% |
| Q2 2022 | $996,000 | -31.9% | 47,863 | -25.9% | 0.00% | 0.0% |
| Q1 2022 | $1,463,000 | -1.3% | 64,553 | -20.4% | 0.00% | 0.0% |
| Q4 2021 | $1,482,000 | -27.4% | 81,060 | -16.0% | 0.00% | -50.0% |
| Q3 2021 | $2,040,000 | +22.6% | 96,521 | +5.7% | 0.01% | +20.0% |
| Q2 2021 | $1,664,000 | +0.8% | 91,307 | +25.0% | 0.01% | 0.0% |
| Q1 2021 | $1,650,000 | +5.8% | 73,031 | -6.1% | 0.01% | -16.7% |
| Q4 2020 | $1,560,000 | -16.0% | 77,747 | +2.3% | 0.01% | -33.3% |
| Q3 2020 | $1,858,000 | +5.4% | 75,989 | +2.3% | 0.01% | 0.0% |
| Q2 2020 | $1,763,000 | +74.9% | 74,246 | +26.8% | 0.01% | +28.6% |
| Q1 2020 | $1,008,000 | -42.0% | 58,564 | -40.7% | 0.01% | -12.5% |
| Q4 2019 | $1,739,000 | -12.1% | 98,710 | -11.8% | 0.01% | -27.3% |
| Q3 2019 | $1,979,000 | -22.4% | 111,893 | -6.3% | 0.01% | -26.7% |
| Q2 2019 | $2,551,000 | -22.8% | 119,374 | -14.0% | 0.02% | -25.0% |
| Q1 2019 | $3,304,000 | +29.2% | 138,826 | +6.8% | 0.02% | +11.1% |
| Q4 2018 | $2,557,000 | -7.9% | 129,970 | -17.0% | 0.02% | -5.3% |
| Q3 2018 | $2,776,000 | -1.9% | 156,672 | +19.2% | 0.02% | 0.0% |
| Q2 2018 | $2,829,000 | -11.4% | 131,476 | -8.8% | 0.02% | -9.5% |
| Q1 2018 | $3,194,000 | -37.1% | 144,206 | -13.6% | 0.02% | -40.0% |
| Q4 2017 | $5,076,000 | +21.7% | 166,972 | -3.0% | 0.04% | -7.9% |
| Q3 2017 | $4,172,000 | +12.8% | 172,194 | +14.7% | 0.04% | +2.7% |
| Q2 2017 | $3,698,000 | -5.9% | 150,149 | -17.2% | 0.04% | -9.8% |
| Q1 2017 | $3,931,000 | +16.8% | 181,419 | -19.6% | 0.04% | +10.8% |
| Q4 2016 | $3,366,000 | +54.2% | 225,770 | +32.3% | 0.04% | +23.3% |
| Q3 2016 | $2,183,000 | +41.1% | 170,647 | -13.9% | 0.03% | +50.0% |
| Q2 2016 | $1,547,000 | +96.8% | 198,085 | +0.8% | 0.02% | +81.8% |
| Q1 2016 | $786,000 | -35.4% | 196,497 | -8.8% | 0.01% | -26.7% |
| Q4 2015 | $1,216,000 | +12.1% | 215,541 | +11.4% | 0.02% | 0.0% |
| Q3 2015 | $1,085,000 | +59.1% | 193,445 | +6.7% | 0.02% | +66.7% |
| Q2 2015 | $682,000 | +36.1% | 181,365 | -6.9% | 0.01% | +50.0% |
| Q1 2015 | $501,000 | +103.7% | 194,899 | +13.9% | 0.01% | +100.0% |
| Q4 2014 | $246,000 | -9.6% | 171,093 | -3.8% | 0.00% | -25.0% |
| Q3 2014 | $272,000 | -62.3% | 177,876 | -16.5% | 0.00% | -55.6% |
| Q2 2014 | $722,000 | -41.0% | 213,079 | -38.3% | 0.01% | -40.0% |
| Q1 2014 | $1,223,000 | +110.9% | 345,604 | +265.6% | 0.02% | +66.7% |
| Q4 2013 | $580,000 | -44.9% | 94,538 | -47.7% | 0.01% | -64.0% |
| Q3 2013 | $1,052,000 | +50.1% | 180,771 | +17.1% | 0.02% | +78.6% |
| Q2 2013 | $701,000 | – | 154,352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |